CHMP review of safety of non-selective NSAIDs, EMEA
What are the conclusions of the CHMP on cardiovascular safety of non-selective NSAIDs?
(I-Newswire) - Following the assessment of available evidence on thrombotic risk ( in particular heart attack and stroke ) and pending the ongoing review of other safety issues, the CHMP currently does not recommend any changes to the advice to patients and prescribers.
What are NSAIDs?
NSAIDs are non-steroidal anti-inflammatory drugs. They have been available on the market for many years and are important in the treatment of arthritis and other painful conditions. COX-2 inhibitors are a subset of the class of NSAIDs, which is made up of two types: the older, conventional “non-selective” NSAIDs and the newer “COX-2 inhibitors” which have more recently become available.
How does the COX-2 inhibitors review relate to non-selective NSAIDs?
Concerns were raised regarding an increased risk of cardiovascular events ( including heart attacks and strokes ) when using COX-2 inhibitors. In November 2004, the EMEA began a Europe-wide review of the COX-2 inhibitors at the request of the European Commission and this was broadened in April 2005 to also include serious skin reactions. The review of COX-2 inhibitors was finalised in June 2005 and the advice published at that time remains valid ( see Question and Answer document on the EMEA web site ( Click Here ). When the CHMP reviewed the safety data for the COX-2 inhibitors, it compared them to non-selective NSAIDs. This suggested the need to assess the safety of non-selective NSAIDs as well, and the review started in June 2005.
Which non-selective NSAIDs and which data are being looked at through this review?
Diclofenac, Etodolac, Ibuprofen, Indomethacin, Ketoprofen, Meloxicam, Nabumetone, Naproxen and Nimesulide. As part of the review on cardiovascular safety of non-selective NSAIDs, the Committee has looked at available epidemiological and clinical data generated by clinical trials and market surveillance.
What are the next steps/possible regulatory actions?
The Committee is reviewing other already known safety concerns ( gastro-intestinal safety and serious skin reactions ) with non-selective NSAIDs and expects to conclude during the plenary meeting of 12-15 September 2005. The Committee will then advise if further actions may be necessary and the EMEA will promptly inform the public of the conclusions.
What are the recommendations for patients and prescribers?
-- Patients and prescribers should continue to use the products as currently recommended.
-- Doctors and patients should closely follow the product information for non-selective NSAIDs ( whether they are prescription or over-the-counter products ). They should use the lowest effective dose for the shortest possible duration of treatment to control symptoms.
-- Doctors should prescribe on the basis of the overall safety profiles of non-selective NSAIDs as set out in product information, and individual risk factors.
-- Patients who have concerns or questions should talk to their doctor or pharmacist at a routine appointment.
If you have questions regarding information in this press release contact the company listed below. I-Newswire.com is a press release service and not the author of this press release. The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies / PR Agencies submit their press releases once per week/month or quarter, make sure check the official company website for accurate release dates as our site displays the I-Newswire.com distribution date only. We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information.
Immerse yourself in mystery and magic with two exciting new casual games from Focus Multimedia and Big Fish Games Studios, one of the world’s leading casual game developers. Hidden Expedition Titanic and Azada join Focus’ popular Revival range of super-budget price games and are available in a store near you.
Edraw Max enables students, teachers and business professionals to reliably create and publish kinds of diagrams to represent any ideas. With large pre-drawn libraries and more than 4600 vector symbols, drawing couldn't be easier!
New range of cards launched to make you the cover star.Hallmark Cards in partnership with OK Magazine has launched an exclusive and exciting new range of greeting cards that gives people the chance to give family and friends the A-List treatment.
Many people choose not to pursue an accident claim. The reasons range from knowing the insurance company will settle; to they don't want the legal hassles and expense.
Many individuals and businesses have always purchased their personal computers from a well-known provider to pre-conceived specifications. Increasingly...
The effectiveness of SEO and PPC Services are directly related to the quality and quantity of the performance data that they have to work with. If you are seeking assistance in achieving a higher ranking on search engine results, then we suggest you visit RankYourWebsites.com, specialist in this area. If you have found your attempts at optimization to prove fruitless, the representatives at RankYourWebsites.com will have a solution to increase your traffic.
http://www.vineyardsforsalein.com/ - online island vineyard for sale, vineyard for sale paso, texas vineyard for sale, washington vineyard for sale, tuscany vineyard for sale, vineyard for sale santa, vineyard for sale California
Mark Flanagan, Managing Director of Manchester health and safety, food safety and fire safety consultancy, Shieldyourself, discussed the Scores on the Doors scheme when he made a guest appearance on the BBC’s 5 Live Radio Show recently.
